Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat

Toxicology

Volumn 287, Issue 1-3, 2011, Pages 29-37

  Shima, Noriaki ^a   Miyawaki, Izuru ^b   Bando, Kiyoko ^b   Horie, Hiroshi ^b   Zaitsu, Kei ^a   Katagi, Munehiro ^a   Bamba, Takeshi ^c   Tsuchihashi, Hitoshi ^d   Fukusaki, Eiichiro ^c  

^a Chuo ward   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Acute intoxication; Biomarker; Central metabolism; Mass spectrometry; Metabolomics; Methamphetamine

Indexed keywords

3 HYDROXYBUTYRIC ACID; 5 OXOPROLINASE; ADIPIC ACID; FRUCTOSE 1,6 BISPHOSPHATE; FUMARIC ACID; GLUCOSE; GLUCOSE 6 PHOSPHATE; METHAMPHETAMINE; SACCHARIC ACID; TRICARBOXYLIC ACID; URACIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CAPILLARY ELECTROPHORESIS; CITRIC ACID CYCLE; CONTROLLED STUDY; ENERGY YIELD; FATTY ACID OXIDATION; GAS CHROMATOGRAPHY; GLYCOLYSIS; INTOXICATION; MALE; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; NERVE CELL; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RAT; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; UROGENITAL SYSTEM;

ACUTE DISEASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BODY TEMPERATURE; CITRIC ACID CYCLE; FATTY ACIDS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLYCOLYSIS; MALE; METABOLOMICS; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

RATTUS;

EID: 79960699502     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.05.012     Document Type: Article

References (43)

1. Albertson T.E., Derlet R.W., Van Hoozen B.E. Methamphetamine and the expanding complications of amphetamines. West J. Med. 1999, 170:214-219.
2. Bando, K., Kunimatsu, T., Sakai, J., Kimura, J., Funabashi, H., Seki, T., Bamba, T., Fukusaki, E. GC-MS-based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats. J. Appl. Toxicol., doi:10.1002/jat.1591, 2010 Dec 10.
3. Bando K., Kawahara R., Kunimatsu T., Sakai J., Kimura J., Funabashi H., Seki T., Bamba T., Fukusaki E. Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies. J. Biosci. Bioeng. 2010, 110:491-499.
4. Berman S.M., Voytek B., Mandelkern M.A., Hassid B.D., Isaacson A., Monterosso J., Miotto K., Ling W., London E.D. Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse. Mol. Psychiatry 2008, 13:897-908.
5. Boudonck K.J., Mitchell M.W., Német L., Keresztes L., Nyska A., Shinar D., Rosenstock M. Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol. Pathol. 2009, 37:280-292.
6. Cahill G.F. Fuel metabolism in starvation. Annu. Rev. Nutr. 2006, 26:1-22.
7. Darke S., Kaye S., McKetin R., Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008, 27:253-262.
8. De Vos R.C., Moco S., Lommen A., Keurentjes J.J., Bino R., Hall R.D. Untargeted large-scale plant metabolomics using liquid chromatography coupled to mass spectrometry. Nat. Protoc. 2007, 2:778-791.
9. Dettmer K., Aronov P.A., Hammock B.D. Mass spectrometry-based metabolomics. Mass Spectrom. Rev. 2007, 26:51-78.
10. Dickinson J.E., Andres R.L., Parisi V.M. The ovine fetal sympathoadrenal response to the maternal administration of methamphetamine. Am. J. Obstet. Gynecol. 1994, 170:1452-1457.
11. Gramsbergen J.B., Cumming P. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats. Neurochem. Int. 2007, 51:8-15.
12. Gudelsky G.A., Yamamoto B.K. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacol. Biochem. Behav. 2008, 90:198-207.
13. Harada K., Ohyama Y., Tabushi T., Kobayashi A., Fukusaki E. Quantitative analysis of anionic metabolites for Catharanthus roseus by capillary electrophoresis using sulfonated capillary coupled with electrospray ionization-tandem mass spectrometry. J. Biosci. Bioeng. 2008, 105:249-260.
14. Herring N.R., Schaefer T.L., Tang P.H., Skelton M.R., Lucot J.P., Gudelsky G.A., Vorhees C.V., Williams M.T. Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. BMC Neurosci. 2008, 9:49-63.
15. Hirayama A., Kami K., Sugimoto M., Sugawara M., Toki N., Onozuka H., Kinoshita T., Saito N., Ochiai A., Tomita M., Esumi H., Soga T. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 2009, 69:4918-4925.
16. Homer B.D., Solomon T.M., Moeller R.W., Mascia A., DeRaleau L., Halkitis P.N. Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications. Psychol. Bull. 2008, 134:301-310.
17. Kim S.J., Lyoo I.K., Hwang J., Sung Y.H., Lee H.Y., Lee D.S., Jeong D.U., Renshaw P.F. Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology 2005, 30:383-1391.
18. Kim S.J., Lyoo I.K., Hwang J., Chung A., Hoon Sung Y., Kim J., Kwon D.H., Chang K.H., Renshaw P.F. Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. Int. J. Neuropsychopharmacol. 2006, 9:221-228.
19. Kim Y.T., Lee S.W., Kwon D.H., Seo J.H., Ahn B.C., Lee J. Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers. J. Psychiatr. Res. 2009, 43:1166-1170.
20. Kuhara T. Diagnosis of inborn errors of metabolism using filter paper urine, urease treatment, isotope dilution and gas chromatography-mass spectrometry. J. Chromatogr. B: Biomed. Sci. Appl. 2001, 758:3-25.
21. Kuhara T. Gas chromatographic-mass spectrometric urinary metabolome analysis to study mutations of inborn errors of metabolism. Mass Spectrom. Rev. 2005, 24:814-827.
22. Kumar B.S., Lee Y.J., Yi H.J., Chung B.C., Jung B.H. Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach. Anal. Chim. Acta 2010, 19:47-59.
23. Lommen A. MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing. Anal. Chem. 2009, 81:3079-3086.
24. Meredith C.W., Jaffe C., Ang-Lee K., Saxon A.J. Implications of chronic methamphetamine use: a literature review. Harv. Rev. Psychiatry 2005, 13:141-154.
25. Park S.H., Sim Y.B., Kang Y.J., Kim S.M., Lee J.K., Jung J.S., Suh H.W. Characterization of blood glucose level regulation in mouse opioid withdrawal models. Neurosci. Lett. 2010, 476:119-122.
26. Perez J.A., Arsura E.L., Strategos S. Methamphetamine-related stroke: four cases. J. Emerg. Med. 1999, 17:469-471.
27. Perrine S.A., Michaels M.S., Ghoddoussi F., Hyde E.M., Tancer M.E., Galloway M.P. Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat. NMR Biomed. 2009, 22:419-425.
28. Robertson D.G. Metabonomics in toxicology: a review. Toxicol. Sci. 2005, 85:809-822.
29. Sailasuta N., Abulseoud O., Harris K.C., Ross B.D. Glial dysfunction in abstinent methamphetamine abusers. J. Cereb. Blood Flow Metab. 2010, 30:950-960.
30. Shiomi, Y., Nishiumi, S., Ooi, M., Hatano, N., Shinohara, M., Yoshie, T., Kondo, Y., Furumatsu, K., Shiomi, H., Kutsumi, H., Azuma, T., Yoshida, M. GC-MS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm. Bowel. Dis., doi:10.1002/ibd.21616, 2011 Feb 1.
31. Soga T., Ohashi Y., Ueno Y., Naraoka H., Tomita M., Nishioka T. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J. Proteome Res. 2003, 2:488-494.
32. Sugimoto M., Wong D.T., Hirayama A., Soga T., Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 2010, 6:78-95.
33. Tata D.A., Raudensky J., Yamamoto B.K. Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia. Eur. J. Neurosci. 2007, 26:739-748.
34. Trygg J., Holmes E., Lundstedt T. Chemometrics in metabonomics. J. Proteome Res. 2007, 6:469-479.
35. Trygg J., Wold S. Orthogonal projections to latent structures (O-PLS). J. Chemom. 2002, 16:119-128.
36. United Nations Office on Drugs and Crime World Drug Report 2010, United Nations Office on Drugs and Crime, Vienna.
37. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M.J., Gatley S.J., Hitzemann R., Ding Y.S., Wong C., Logan J. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am. J. Psychiatry 2001, 158:383-389.
38. Wang G.J., Volkow N.D., Chang L., Miller E., Sedler M., Hitzemann R., Zhu W., Logan J., Ma Y., Fowler J.S. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am. J. Psychiatry 2004, 161:242-248.
39. Wiklund S., Johansson E., Sjoestroem L., Mellerowicz E.J., Edlund U., Shockcor J.P., Gottfries J., Moritz T., Trygg J. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal. Chem. 2007, 80:116-123.
40. Wohlfarth A., Weinmann W. Bioanalysis of new designer drugs. Bioanalysis 2010, 2:965-979.
41. Yu Y.M., Ryan C.M., Fei Z.W., Lu X.M., Castillo L., Schultz J.T., Tompkins R.G., Young V.R. Plasma l-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E247-258.
42. Yuan J., Hatzidimitriou G., Suthar P., Mueller M., McCann U., Ricaurte G. Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys. J. Pharmacol. Exp. Ther. 2006, 316:1210-1218.
43. Zhao H., Steinberg G.K., Sapolsky R.M. General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage. J. Cereb. Blood Flow Metab. 2007, 27:1879-1894.